Rebalix
Logo UBSUBS · sheet of 10 September 2026
ETF sheet · official issuer and register data

UBS Core MSCI USA UCITS ETF USD acc

IE00BD4TXS21 · IE00BD4TXS21 · USD · domicile Ireland
Equity · United StatesSFDR art. 6
Index tracked: MSCI USA Total Return Net
TER
0.03%+ trans. 0.00%
Fund size
2.7 bn EUR
Tracking difference
+0.18%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 16 Sept 2016 · costs from the KID as of 2 Sept 2026 · 520 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and seeks to track performance of the MSCI USA Index (Net Return) (the 'Index'). The Index is designed to measure the performance of mid and large capitalisation companies which are listed on markets in the USA. The Fund will seek to hold all of the shares of the Index, in the same proportions as the Index, so that essentially the portfolio of the Fund will be a near mirror image of the Index. In seeking to implement its investment objective of tracking the performance of the Index, the Fund may also in exceptional…

Performance since series start (in euro) — base 100

16 Sept 20168 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2017201920212023202540199394
High 401 (7 Aug 2026) · low 99 (3 Nov 2016) · last 394. Past performance is not indicative of future results.

Returns in euro

1 year+20.1%
3 years+64.1%
5 years+79.8%
10 years+294.4%
Since series start+294.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.01%15.16%17.37%
Max drawdown−9.08%−19.15%−25.58%
Sharpe1.251.140.60
Sortino1.801.670.87
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BD4TXS21 · IE00BD4TXS211
RebalixIE00BD4TXS21 · IE00BD4TXS21 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+17.49%+17.31%+0.18%
2024+24.75%+24.58%+0.17%
2023+26.67%+26.49%+0.18%
2022−19.75%−19.85%+0.09%
2021+26.55%+26.45%+0.09%

Holdings

Portfolio as declared by the issuer · 19 Aug 2026 · 520 securities · top-10 weight = 36.4%
Top holdingsWeight
NVIDIA CORP7.6%
APPLE INC7.0%
MICROSOFT CORP5.2%
AMAZON.COM INC3.9%
ALPHABET INC-CL A3.0%
BROADCOM INC2.5%
ALPHABET INC-CL C2.4%
META PLATFORMS INC-CLASS A1.8%
MICRON TECHNOLOGY INC1.6%
ELI LILLY & CO1.6%
Sectors (% of fund)
Informatica37.4%Finanza11.6%Servizi di comunicazione9.8%Beni di consumo9.4%Industriali9.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
USAUSW · Borsa Italiana (ETFplus)
4UBB · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ubs.com/2/e/priip/PRIIPSEU_IE00BD4TXS21_en_IE.pdf
Factsheet · www.ubs.com/2/e/files/RET/FS_RET_IE00BD4TXS21_IT_IT.pdf
Prospectus · www.ubs.com/2/e/files/ubs_irl_etf_plc_peit.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BD4TXS21
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE00BD4TXS21 · IE00BD4TXS212